Literature DB >> 15989987

Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.

P Drakakis1, D Loutradis, K Kallianidis, A Liapi, S Milingos, A Makrigiannakis, A Dionyssiou-Asteriou, S Michalas.   

Abstract

OBJECTIVE: To examine whether exogenous LH administration has a beneficial effect on the quality of oocytes, fertilization potential, as well as pregnancy rate in IVF-ET cycles. A randomized trial comparing r-FSH versus r-FSH and LH was employed. STUDY
DESIGN: Forty-six infertile couples entering IVF-ET for the first time (either tubal or male factor) were divided after prospective randomization into two groups. In both groups the long protocol with GnRH-analogs was used. In group A, ovarian stimulation started with r-FSH (200 IU/day) for the first four days. In group B, the stimulation protocol started with one amp hMG (75 IU FSH + 75 IU LH activity) daily for four days, with simultaneous administration of r-FSH (150 IU/day). The outcome was compared.
RESULTS: Statistical difference was observed in the number of mature oocytes, the number of fertilized oocytes as well as the number of transferable embryos. In all cases, results were statistically significantly better (p < 0.05) in group B. Clinical pregnancy rate, finally, was similar in the two groups.
CONCLUSION: The relatively small sample size does not allow a definitive conclusion for the important role of LH during early oocyte maturation. Our results, however, indicate a beneficial effect when small doses of LH are used for ovarian stimulation in IVF-ET cycles. This effect may be more important in cases in which few embryos are available for transfer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15989987     DOI: 10.1016/j.ejogrb.2004.12.021

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

1.  LH receptor gene expression in cumulus cells in women entering an ART program.

Authors:  Myrto Papamentzelopoulou; Despina Mavrogianni; George A Partsinevelos; Spyros Marinopoulos; Vasiliki Dinopoulou; Charalampos Theofanakis; Elli Anagnostou; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2012-03-01       Impact factor: 3.412

Review 2.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

3.  Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation.

Authors:  Peter Drakakis; Dimitris Loutradis; Apostolos Beloukas; Vana Sypsa; Vasiliki Anastasiadou; George Kalofolias; Helen Arabatzi; Erasmia Kiapekou; Konstantinos Stefanidis; Dimitris Paraskevis; Antonis Makrigiannakis; Angelos Hatzakis; Aris Antsaklis
Journal:  Reprod Biol Endocrinol       Date:  2009-10-13       Impact factor: 5.211

4.  Effect of recombinant LH supplementation timing on clinical pregnancy outcome in long-acting GnRHa downregulated cycles.

Authors:  Chenyang Huang; Xiaoyue Shen; Jie Mei; Yanxin Sun; Haixiang Sun; Jun Xing
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-09       Impact factor: 3.105

5.  "hCG priming" effect in controlled ovarian stimulation through a long protocol.

Authors:  Panagiotis Beretsos; George A Partsinevelos; Eleni Arabatzi; Peter Drakakis; Depy Mavrogianni; Elli Anagnostou; Kostas Stefanidis; Aris Antsaklis; Dimitris Loutradis
Journal:  Reprod Biol Endocrinol       Date:  2009-08-31       Impact factor: 5.211

6.  A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART.

Authors:  Charalampos Siristatidis; Sofoklis Stavros; Konstantinos Dafopoulos; Theodoros Sergentanis; Ekaterini Domali; Peter Drakakis; Dimitrios Loutradis
Journal:  Reprod Sci       Date:  2021-07-12       Impact factor: 3.060

7.  A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols.

Authors:  Nathalie Bleau; Mohammed Agdi; WeonYoung Son; SeangLin Tan; Michael H Dahan
Journal:  Int J Fertil Steril       Date:  2017-02-16

Review 8.  Past, Present, and Future of Gonadotropin Use in Controlled Ovarian Stimulation During Assisted Reproductive Techniques.

Authors:  Anastasia Prodromidou; Elli Anagnostou; Depy Mavrogianni; Emmanouela Liokari; Evangelia Dimitroulia; Petros Drakakis; Dimitrios Loutradis
Journal:  Cureus       Date:  2021-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.